Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


28.01.2019

1 Am J Hematol
2 Blood
1 Bone Marrow Transplant
1 Br J Haematol
3 Int J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Am Acad Dermatol
1 J Clin Oncol
1 Lab Invest
2 Lancet Oncol
3 Leuk Lymphoma
1 Leukemia
1 Mod Pathol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. DE LA FUENTE MI, Alderuccio JP, Reis IM, Omuro A, et al
    Bilateral Radiation Therapy followed by Methotrexate-based Chemotherapy for Primary Vitreoretinal Lymphoma.
    Am J Hematol. 2019 Jan 21. doi: 10.1002/ajh.25414.
    PubMed     Text format     Abstract available


    Blood

  2. ZHAO X, Tao J
    BRD4: epigenetic origin and target of CTCL.
    Blood. 2018;131:712-713.
    PubMed     Text format    

  3. WASIK MA
    Distinct miRNA profile in prognosis of early CTCL.
    Blood. 2018;131:711.
    PubMed     Text format    


    Bone Marrow Transplant

  4. FUJI S, Yamaguchi T, Inoue Y, Utsunomiya A, et al
    VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0446.
    PubMed     Text format     Abstract available


    Br J Haematol

  5. CANNATA-ORTIZ J, Nicolas C, Garcia-Noblejas A, Requena MJ, et al
    Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI >/= 2 follicular lymphoma. Final results of the LNH-PRO-05 study.
    Br J Haematol. 2019 Jan 17. doi: 10.1111/bjh.15760.
    PubMed     Text format    


    Int J Cancer

  6. WANG X, Zhang T, Song Z, Li L, et al
    Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: Correlations with clinicopathological characteristics and clinical outcome.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32144.
    PubMed     Text format     Abstract available

  7. WEIBULL CE, Bjorkholm M, Glimelius I, Lambert PC, et al
    Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32142.
    PubMed     Text format     Abstract available

  8. YE X, Zhang G, Righolt C, Johnston JB, et al
    Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
    Int J Cancer. 2018;143:971-979.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  9. MARQUEZ C
    Observe, and Keep Chemotherapy Up the Sleeve.
    Int J Radiat Oncol Biol Phys. 2018;100:550.
    PubMed     Text format    

  10. KALLAM A, Armitage JO
    Watch and Wait, Salvage Later.
    Int J Radiat Oncol Biol Phys. 2018;100:549-550.
    PubMed     Text format    

  11. SANGHVI P
    Involved-Site Radiation to Maximize Control.
    Int J Radiat Oncol Biol Phys. 2018;100:549.
    PubMed     Text format    


    J Am Acad Dermatol

  12. GELLER S, Navarrete-Dechent C, Myskowski PL
    Dermoscopy in lymphoproliferative disorders - experience from a cutaneous lymphoma clinic in a tertiary cancer center.
    J Am Acad Dermatol. 2019 Jan 14. pii: S0190-9622(19)30074.
    PubMed     Text format    

  13. YUKI A, Shinkuma S, Hayashi R, Fujikawa H, et al
    CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
    J Am Acad Dermatol. 2018;79:1039-1046.
    PubMed     Text format     Abstract available


    J Clin Oncol

  14. COOK LB, Fuji S, Hermine O, Bazarbachi A, et al
    Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.
    J Clin Oncol. 2019 Jan 18:JCO1800501. doi: 10.1200/JCO.18.00501.
    PubMed     Text format     Abstract available


    Lab Invest

  15. NAGATO T, Ueda S, Takahara M, Kishibe K, et al
    Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.
    Lab Invest. 2019 Jan 21. pii: 10.1038/s41374-018-0182.
    PubMed     Text format     Abstract available


    Lancet Oncol

  16. CASASNOVAS RO, Bouabdallah R, Brice P, Lazarovici J, et al
    PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
    Lancet Oncol. 2019 Jan 15. pii: S1470-2045(18)30784.
    PubMed     Text format     Abstract available

  17. FITZGERALD TJ
    Optimisation of adaptive therapy for advanced Hodgkin lymphoma.
    Lancet Oncol. 2019 Jan 15. pii: S1470-2045(19)30005.
    PubMed     Text format    


    Leuk Lymphoma

  18. WANG J, Van Den Berg D, Hwang AE, Weisenberger D, et al
    DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.
    Leuk Lymphoma. 2019 Jan 22:1-9. doi: 10.1080/10428194.2018.1533128.
    PubMed     Text format     Abstract available

  19. CLAUSEN MR, Ulrichsen SP, Larsen TS, Poulsen CB, et al
    Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
    Leuk Lymphoma. 2019 Jan 22:1-8. doi: 10.1080/10428194.2018.1554863.
    PubMed     Text format     Abstract available

  20. MESSMER M, Tsai HL, Varadhan R, Swinnen LJ, et al
    R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma.
    Leuk Lymphoma. 2019 Jan 18:1-5. doi: 10.1080/10428194.2018.1519812.
    PubMed     Text format     Abstract available


    Leukemia

  21. VEKARIA PH, Kumar A, Subramaniam D, Dunavin N, et al
    Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.
    Leukemia. 2019 Jan 21. pii: 10.1038/s41375-018-0355.
    PubMed     Text format     Abstract available


    Mod Pathol

  22. LI L, Sun R, Miao Y, Tran T, et al
    PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Progra
    Mod Pathol. 2019 Jan 21. pii: 10.1038/s41379-018-0193.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: